Press release
Generic Injectables Market to Reach US$ 65.4 Billion by 2027, Propelled by Favorable Government Initiatives
According to the latest report by IMARC Group, titled "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global generic injectables market reached a value of US$ 40.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 65.4 Billion by 2027, exhibiting at a CAGR of 8.6% during 2022-2027.Generic injectables refer to drugs with the same active pharmaceutical ingredient as their branded counterparts. They are equivalent in dosage form, performance, intended use, strength, safety, quality, and route of administration. They are used to administer the medication rapidly into the body and are as safe and effective as the innovator drug. Additionally, they facilitate the easy absorption of medicines in liquid form, which further declines the frequency of dosage administration without affecting the treatment's efficacy. Besides this, they are cost-effective since they do not require investment in research and development (R&D), testing, and promotional activities compared to branded injectable drugs.
Request for a free sample copy of this report: https://www.imarcgroup.com/generic-injectables-market/requestsample
The growing prevalence of chronic illnesses primarily drives the generic injectables market. This is supported by the increasing incidences of chronic medical ailments, such as diabetes, osteoarthritis, rheumatoid arthritis, cancer, and cardiovascular, neurological, and respiratory disorders. Along with this, the rising occurrence of lifestyle disorders as a result of changing dietary patterns, hectic schedules, and sedentary lifestyles of individuals is significantly supporting the market. At present, government and monetary specialists are setting new projects as well as financial plans for nonexclusive injectables engineers to improve their business discernment. This acts as one of the major growth-inducing factors.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/generic-injectables-market
Industry Growth:
Apart from this, the increasing preference for generic injectable products over their counterparts is due to their advantages, such as improved availability of biologic drugs in development pipelines, faster approvals, and a higher preference for injectable drug delivery is positively influencing the market growth. Additionally, the cost-effectiveness and better patient outcomes accelerating the sales of generic injectables, including monoclonal antibodies, immunoglobulins, antibodies, vaccines, and peptides, is propelling the market growth. Moreover, the emerging trend of online shopping offers consumers a wide range of products, is creating a positive market outlook. Other factors driving the market further include the growing geriatric population and rising health awareness among the masses.
Key Segmentation:
Competitive Landscape with Key Players:
• Hospira, Inc. (Pfizer Inc.)
• Fresenius Kabi AG
• Hikma Pharmaceuticals PLC
• Sandoz (Novartis)
• Sagent M&C, LLC
• Sanofi S.A.
• Baxter International, Inc.
Also, Read Top Players in the Generic Injectables Market: https://www.imarcgroup.com/generic-injectables-companies
Breakup by Therapeutic Area:
• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular
Breakup by Container:
• Vials
• Ampoules
• Premix
• Prefilled Syringes
Breakup by Distribution Channel:
• Hospitals
• Retail Pharmacy
Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Other Reports of IMARC Group:
• https://www.imarcgroup.com/shipping-container-market
• https://www.imarcgroup.com/polymer-coated-fabrics-market
• https://www.imarcgroup.com/veterinary-pain-management-market
• https://www.imarcgroup.com/quantum-dots-market
• https://www.imarcgroup.com/structural-health-monitoring-market
• https://www.imarcgroup.com/nanofibers-market
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Injectables Market to Reach US$ 65.4 Billion by 2027, Propelled by Favorable Government Initiatives here
News-ID: 2845619 • Views: …
More Releases from IMARC Group

Automotive Control Cables Manufacturing Plant Setup Report 2025: Machinery, Raw …
Automotive control cables are essential components used to transmit mechanical force in vehicles, enabling the smooth operation of various systems such as brakes, clutches, accelerators, gear shifts, and seating mechanisms. These cables are designed for durability, flexibility, and high performance under diverse driving conditions. Their demand is directly linked to the growth of the automotive industry, aftermarket sales, and increasing consumer preference for enhanced driving comfort and safety.
Setting up an…

Halal Cosmetics Market Size, Trends, Key Players, Opportunity and Forecast 2025- …
IMARC Group, a leading market research company, has recently released a report titled "Halal Cosmetics Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global halal cosmetics market size, trends, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Halal Cosmetics Market Highlights:
• Halal Cosmetics Market…

Comprehensive Castor Oil Processing Plant Project Report 2025: Setup Guide, Econ …
Castor oil is a versatile vegetable oil extracted from the seeds of the Ricinus communis plant. It is widely used in pharmaceuticals, cosmetics, food processing, lubricants, paints, coatings, and biodiesel production owing to its unique chemical properties, including high ricinoleic acid content. Castor oil derivatives also serve as key raw materials in the polymer, chemical, and industrial sectors.
Establishing a castor oil processing plant involves steps such as seed cleaning, dehulling,…

Honey Processing Plant Report 2025: Capital Investment, Operating Expenses and M …
Honey is a natural sweetener produced by honeybees and is valued for its nutritional, medicinal, and industrial applications. It contains antioxidants, enzymes, vitamins, and minerals that make it a popular ingredient in food and beverages, pharmaceuticals, cosmetics, and personal care products. Processed honey is widely consumed as a sweetener, used in bakery and confectionery items, beverages, dietary supplements, and skincare formulations.
Setting up a honey processing plant involves operations such as…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…